Best Serverless Security Practices from the 4th AWS & Intetics Joint Webinar, Now Available on YouTube
NAPLES, Fla., April 12, 2023 (GLOBE NEWSWIRE) — The 4th joint webinar “Serverless Security on…
NAPLES, Fla., April 12, 2023 (GLOBE NEWSWIRE) — The 4th joint webinar “Serverless Security on…
Oakville, Ontario–(Newsfile Corp. – April 12, 2023) – FendX Technologies Inc. (CSE: FNDX) (the “Company”…
Land Avion, a private property acquisition company based in New Mexico, has expanded its cash…
Toyota City, Japan, Apr 12, 2023 – (JCN Newswire) – TOYOTA is releasing details on…
HONG KONG, Apr 12, 2023 – (ACN Newswire) – The first-ever InnoEX, jointly organised by…
SINGAPORE, Apr 12, 2023 – (ACN Newswire) – Infocus International Group, a global business intelligence…
CHICAGO–(BUSINESS WIRE)–With over 40 years of industry expertise, Brian Rosen has established a specialty lending…
Li-Cycle assessing opportunity to develop a dedicated Spoke recycling plant in Vietnam near VinES’ lithium-ion…
To address the global demand for high-quality face recognition as a part of identity verification,…
SAN FRANCISCO–(BUSINESS WIRE)–Mintegral, a prominent global programmatic advertising platform for app developers, recently revealed its…
KARIYA, JAPAN, Apr 12, 2023 – (JCN Newswire) – DENSO, a leading mobility supplier, has…
SEOUL, South Korea/TOKYO, Japan, Apr 12, 2023 – (JCN Newswire) – POSCO Holdings Inc. (POSCO)…
MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–intoPIX and Lawo proudly announce that, following the popularity of Lawo’s vm_jpegXS app…
SHANGHAI, China, April 11, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
SHANGHAI, China, April 11, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
Samsung Ventures makes investment in Araris Proceeds will be used to support further development and…
JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2023 (GLOBE NEWSWIRE) —…
SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Company to share preliminary safety and efficacy data from ongoing Phase 1/2 trial of OCU400…